BGLC vs GE · rev $99.0K vs P/E 44, rev $13.35B
BioNexus Gene Lab Corp Common stock (BGLC) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
BGLC currently screens at market cap $6.1M. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the BGLC and GE stock pages for the full models.
Not investment advice.